LATEST

Verbal anesthesia: How it’s used in urologic procedures
Hospital ratings correlate with Ca surgery outcomesMedicare beneficiaries who undergo major urologic cancer surgery at hospitals with higher Hospital Compare Star Ratings introduced by the Centers for Medicare & Medicaid Services in 2016 have superior short-term outcomes than patients operated on at hospitals with lower Hospital Compare rating, according to data presented at the AUA annual meeting in Boston.
Have you ever felt threatened by a patient?"Things have gotten worse. Patients are definitely more demanding," says urologist Casey McCullough, DO.
How your practice can avoid medical necessity denialsThe practical application of medical necessity has taken many forms, and in this increasingly complex world of health care, understanding these applications has become a critical component of your business.
A chief urology resident’s 7 lessons in leadership"Learning from my junior residents means realizing that sometimes, maybe even oftentimes, they may know more than I do," writes Amy Pearlman, MD.
Vibration therapy promising for treating stone fragmentsBadar M. Mian, MD, discusses a recent study about the use of external physical vibration lithecbole for treating residual stones after retrograde intrarenal surgery.
Telephone triage can jeopardize patient safety, lead to litigationLawsuits involving telephone triage tend to allege failure in a physician’s duty to treat, abandonment of the patient, or provision of sub-standard care.
Visiting professorships offer unique benefit to residentsUrology resident Nirmish Singla, MD, discusses the insight he’s gained from the experiences and perspectives of visiting professors and residents.
Teamwork essential if oral PCa agents are used in office setting"The nurse practitioner, nurse, and other ancillary providers who make up the urology team are an essential and valuable asset in the consideration of adding oral androgen receptor inhibitors into the office setting," writes Gwendolyn Hooper, PhD, APRN.
Urologists positive about abiraterone integrationMore than 96% of urologists surveyed said that incorporating abiraterone acetate (ZYTIGA) treatment into practice for patients with metastatic castrate-resistant prostate cancer is easy or manageable after overcoming initial barriers, according to new research presented at the Genitourinary Cancers Symposium in Orlando, FL.

Poll